Geet Madhukar

About

I am a computational biologist currently serving as a postdoc at the University of New Hampshire. My current focus involves data-driven molecular modeling of PDE6, incorporating chemical crosslink data. In my previous research endeavors, I specialized in identifying therapeutic compounds for the treatment of head and neck squamous cell carcinoma. My approach integrated high throughput screening, molecular docking, and molecular dynamics techniques. My contributions to the field are reflected in the publication of several research papers and a book chapter in reputable journals. My work underscores a commitment to advancing molecular understanding and finding innovative solutions for medical challenges.

Employment

• University System of New Hampshire Postdoc Research Associate
  2023 - Present
• Jawaharlal Nehru University PhD fellow
  2017 - 2022
• Intas Pharmaceuticals (India) Associate Engineer
  2014 - 2015

Education

• Jawaharlal Nehru University Ph.D. in Computational Biology and Bioinformatics
  2017 - 2022
• University of Rajasthan MTech - Biotechnology and Bioinformatics
  2012 - 2014
• University of Rajasthan BTech
  2008 - 2012

Projects & Funding

Projects & funding information is unavailable.

Publications (12)

• E3 ubiquitin ligases and their therapeutic potential in disease Management
  Biochemical Pharmacology 2025 DOI: 10.1016/j.bcp.2025.116875
  +Save
• Machine Learning-Driven Consensus Modeling for Activity Ranking and Chemical Landscape Analysis of HIV-1 Inhibitors
  Pharmaceuticals 2025
  +Save
• Machine Learning-Driven Consensus Modeling for Activity Ranking and Chemical Landscape Analysis of HIV-1 Inhibitors
  Pharmaceuticals 2025 DOI: 10.3390/ph18050714
  +Save
• Unveiling the Landscape of Cancer: From Therapeutic Targets to their Inhibition
  Recent Trends in Diabetes and Cancer Research and its Management 2024
  +Save
• Potential inhibitors of RPS6KB2 and NRF2 in head and neck squamous cell carcinoma
  Journal of Biomolecular Structure and Dynamics 2024 DOI: 10.1080/07391102.2023.2205946
  +Save
• Current and Potential Pharmacological Targets for Therapeutic Intervention in Head and Neck Squamous Cell Carcinoma
  Socio-Scientific Interaction in Diabetes and Cancer and Its Management 2023 DOI: 10.9734/bpi/mono/978-81-968135-7-4/ch5
  +Save
• Identification of potent and novel inhibitors against RAC1: a Rho family GTPase
  In Silico Pharmacology 2022 DOI: 10.1007/s40203-022-00127-z
  +Save
• Exploring GPR109A Receptor Interaction with Hippuric Acid Using MD Simulations and CD Spectroscopy
  International Journal of Molecular Sciences 2022 DOI: 10.3390/ijms232314778
  +Save
• Identification of Potent and Novel Inhibitors against Dual specificity mitogen-activated protein kinase kinase 1 (MEK1)
  Research Square 2022 DOI: 10.21203/rs.3.rs-2298439/v1
  +Save
• Current and Future Therapeutic Targets: A Review on Treating Head and Neck Squamous Cell Carcinoma.
  Current cancer drug targets 2020 DOI: 10.2174/1568009620666201229120332
  +Save